data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Eagle Pharmaceuticals
(NASDAQ:EGRX)
$46.69
2.26[5.09%]
At close: Jul 1
$46.69
00
After Hours: 4:04PM EDT
Day High/Low44.15 - 46.75
52 Week High/Low41.01 - 58.25
Open / Close44.33 / 46.69
Float / Outstanding7.2M / 13.2M
Vol / Avg.168.8K / 136.6K
Mkt Cap617M
P/E16.79
50d Avg. Price44.83
Div / Yield-
Payout Ratio-
EPS3.47
Total Float7.2M

Eagle Pharmaceuticals (NASDAQ:EGRX), Quotes and News Summary

Eagle Pharmaceuticals (NASDAQ: EGRX)

Day High/Low44.15 - 46.75
52 Week High/Low41.01 - 58.25
Open / Close44.33 / 46.69
Float / Outstanding7.2M / 13.2M
Vol / Avg.168.8K / 136.6K
Mkt Cap617M
P/E16.79
50d Avg. Price44.83
Div / Yield-
Payout Ratio-
EPS3.47
Total Float7.2M
Benzinga - Jun 15, 2022, 10:45AM
Benzinga - Jun 7, 2022, 4:13PM
Benzinga - Jun 1, 2022, 6:51AM
Benzinga - May 9, 2022, 6:51AM
Benzinga - Apr 19, 2022, 6:51AM
Benzinga - Mar 28, 2022, 11:33AM
Benzinga - Mar 28, 2022, 4:53AM
Benzinga - Mar 7, 2022, 12:05PM
Benzinga - Mar 7, 2022, 6:52AM
Benzinga - Mar 7, 2022, 6:51AM
Benzinga - Feb 1, 2022, 6:52AM
Benzinga - Jan 31, 2022, 6:51AM
Benzinga - Jan 18, 2022, 6:51AM
Benzinga - Jan 5, 2022, 1:43PM
Benzinga - Dec 29, 2021, 11:29AM
Benzinga - Dec 20, 2021, 11:39AM
Benzinga - Dec 15, 2021, 3:50PM
Benzinga - Dec 15, 2021, 1:55PM
Benzinga - Nov 9, 2021, 6:54AM
load more
Sector: Health Care.Industry: Biotechnology
Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-08
REV
Q1 2022Est.ActualSurprise
EPS3.8804.040 0.1600
REV123.330M115.874M-7.456M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Eagle Pharmaceuticals Questions & Answers

Q
How do I buy Eagle Pharmaceuticals (EGRX) stock?
A

You can purchase shares of Eagle Pharmaceuticals (NASDAQ: EGRX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Eagle Pharmaceuticals's (EGRX) competitors?
Q
What is the target price for Eagle Pharmaceuticals (EGRX) stock?
A

The latest price target for Eagle Pharmaceuticals (NASDAQ: EGRX) was reported by Cantor Fitzgerald on Monday, March 2, 2020. The analyst firm set a price target for 46.00 expecting EGRX to fall to within 12 months (a possible -1.48% downside). 0 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Eagle Pharmaceuticals (EGRX)?
A

The stock price for Eagle Pharmaceuticals (NASDAQ: EGRX) is $46.69 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Eagle Pharmaceuticals (EGRX) pay a dividend?
A

There are no upcoming dividends for Eagle Pharmaceuticals.

Q
When is Eagle Pharmaceuticals (NASDAQ:EGRX) reporting earnings?
A

Eagle Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 8, 2022.

Q
Is Eagle Pharmaceuticals (EGRX) going to split?
A

There is no upcoming split for Eagle Pharmaceuticals.

Q
What sector and industry does Eagle Pharmaceuticals (EGRX) operate in?
A

Eagle Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.